Would like to have some spare $'s, as the momentum is definitely positive. Admittedly they are spending more money, though it is a necessity as they grow their footprint to service foreign markets, and have product available in these jurisdictions. R&D grant was a large percentage of cash flow, and forecast ineligibility for FY21 should be offset by the gain in sales revenue. Management appear to have a downbeat forward forecast, but are positioning for growth with the supply partnerships they are building.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
GSS
genetic signatures limited
Add to My Watchlist
0.00%
!
37.0¢

Would like to have some spare $'s, as the momentum is definitely...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $84.04M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 37.0¢ | $740 | 2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 27000 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27000 | 0.370 |
1 | 10000 | 0.365 |
3 | 8407 | 0.360 |
1 | 40000 | 0.355 |
4 | 130509 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 20000 | 1 |
0.400 | 111918 | 2 |
0.420 | 40000 | 2 |
0.455 | 5000 | 1 |
0.480 | 500 | 1 |
Last trade - 10.00am 15/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online